INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 30 filers reported holding INTEC PHARMA LTD JERUSALEM in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $72,000 | -50.3% | 332,461 | +9.8% | 0.00% | -40.0% |
| Q4 2019 | $145,000 | +215.2% | 302,909 | +392.1% | 0.01% | +150.0% |
| Q3 2019 | $46,000 | -79.2% | 61,558 | +18.8% | 0.00% | -71.4% |
| Q2 2019 | $221,000 | -9.8% | 51,838 | +54.9% | 0.01% | -41.7% |
| Q1 2019 | $245,000 | -5.8% | 33,469 | -3.1% | 0.01% | 0.0% |
| Q4 2018 | $260,000 | -7.1% | 34,548 | -30.2% | 0.01% | +9.1% |
| Q3 2018 | $280,000 | +60.0% | 49,514 | +74.6% | 0.01% | 0.0% |
| Q1 2018 | $175,000 | – | 28,356 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,528,000 | 1.74% |
| DAFNA Capital Management LLC | 135,000 | $756,000 | 0.75% |
| Cormorant Asset Management, LP | 800,000 | $4,480,000 | 0.72% |
| Perceptive Advisors | 700,000 | $3,920,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 613,910 | $3,438,000 | 0.14% |
| Ion Asset Management Ltd. | 10,000 | $56,000 | 0.08% |
| JANE STREET GROUP, LLC | 34,317 | $194,000 | 0.00% |
| UBS Group AG | 1,296 | $7,000 | 0.00% |